Remodulin
Product Images NDC 66302-111

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Remodulin (NDC 66302-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by United Therapeutics Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Remodulin 01)

Chemical structure of the active ingredient shown in the product data for Remodulin by United Therapeutics Corporation. The diagram depicts the molecular structure with rings, hydroxyl groups, and side chains characteristic of the compound.*

FDA Label Image

Figure 1 (Remodulin 02)

A Kaplan-Meier survival curve illustrating the percentage of subjects without a clinical deterioration event over days on study up to 60 days. The chart compares Remodulin treatment (solid line) to placebo (dashed line), showing higher event-free survival with Remodulin, with a p-value of 0.000228 indicating statistical significance.*

FDA Label Image

Principal Display Panel (1 mg/mL Vial Carton)

Remodulin 20 mg/20 mL (1 mg/mL) multidose vial packaging label for treprostinil injection by United Therapeutics Corporation. The label indicates use for subcutaneous or intravenous infusion only, with storage instructions and caution to keep out of reach of children. The label includes a barcode, lot, expiration, serial numbers, and manufacturing location in the USA.*

FDA Label Image

Principal Display Panel (2.5 mg/mL Vial Carton)

Packaging label for Remodulin (treprostinil) injection, 50 mg/20 mL (2.5 mg/mL), in a 20 mL multidose vial. The label indicates that it is for subcutaneous or intravenous infusion only, manufactured by United Therapeutics Corporation. Storage instructions and components of the solution are noted, along with regulatory information and a barcode.*

FDA Label Image

Principal Display Panel (5 mg/mL Vial Carton)

Packaging label for Remodulin (treprostinil) Injection, 100 mg/20 mL (5 mg/mL) strength, presented as a 20 mL multidose vial. The label indicates use for subcutaneous or intravenous infusion only and includes storage instructions and manufacturer United Therapeutics Corporation.*

FDA Label Image

Principal Display Panel (10 mg/mL Vial Carton)

Remodulin 200 mg/20 mL (10 mg/mL) treprostinil injection packaging label for a 20 mL multidose vial. The label includes product name, strength, usage for subcutaneous or intravenous infusion only, storage instructions, ingredients, and the United Therapeutics Corporation logo. The label also shows barcode and lot, expiration, serial, and GTIN spaces.*

FDA Label Image

Principal Display Panel (50mL Vial Carton)

Packaging label for Remodulin (treprostinil) Injection 400 mg/20 mL (20 mg/mL) from United Therapeutics Corporation. The label indicates a 20 mL multidose vial for subcutaneous or intravenous infusion only. It includes storage instructions, ingredient details, manufacturer information, and a barcode on a fold-out carton template.*

FDA Label Image

Remodulin 08

Packaging label for Remodulin sterile diluent 1 x 50 mL vial. The label states it contains drug diluent for use only with intravenous infusion of REMODULIN (treprostinil) injection. Includes storage instructions and manufacturer United Therapeutics Corporation. Label features red text, a red abstract logo, and barcodes with NDC 66302-150-50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.